Therapeutics to block autoantibody initiation and propagation in systemic lupus erythematosus and rheumatoid arthritis

Estándar

Abstract

Most current therapies for the autoimmune diseases systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), as well as many of the drugs in the therapeutic pipeline, reduce the autoimmune inflammatory process but lead to a general immunosuppression. The goal of the next generation of therapies should be to reduce autoimmunity while at the same time better maintain immunocompetence. We propose three approaches for accomplishing this goal: (i) modulate antigen presentation to the adaptive immune system, (ii) alter B cell selection in the germinal center, and (iii) use decoy antigens to prevent the formation of proinflammatory immune complexes.

These approaches are based on recent advances in the field: We now appreciate the role of dendritic cell function in autoimmune disease and the importance of citrullinated proteins as neoantigens in RA. There is also new recognition that most pathogenic autoantibodies are produced by B cells that have matured within the germinal center and that immune complexes in both diseases contain ligands for Toll-like receptors. We propose that treatments that target these newly revealed aspects of RA and SLE will decrease systemic inflammation with less immunocompromise.
Copyright © 2015, American Association for the Advancement of Science
Citation: J. Suurmond, Y. R. Zou, S. J. Kim, B. Diamond, Therapeutics to block autoantibody initiation and propagation in systemic lupus erythematosus and rheumatoid arthritis. Sci. Transl. Med. 7, 280ps5 (2015).

Un comentario en “Therapeutics to block autoantibody initiation and propagation in systemic lupus erythematosus and rheumatoid arthritis

  1. The authors are proposing a new mechanism of action for drugs to be used in the future to treat SLE, RA and other autoimmune diseases. They speculated that drugs used in nowadays are immunosuppressive. Drugs for autoimmune disorders in the future they should reduce autoimmunity and maintain at the same time immunocompetence

    Me gusta

Responder

Introduce tus datos o haz clic en un icono para iniciar sesión:

Logo de WordPress.com

Estás comentando usando tu cuenta de WordPress.com. Cerrar sesión /  Cambiar )

Google+ photo

Estás comentando usando tu cuenta de Google+. Cerrar sesión /  Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión /  Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión /  Cambiar )

w

Conectando a %s